Literature DB >> 29373150

Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling.

Zhongchi Li1, Kang Xu1, Nannan Zhang1, Gabriel Amador2, Yanying Wang3, Sen Zhao3, Liyuan Li1, Ying Qiu4, Zhao Wang5.   

Abstract

Sirtuin 6 (SIRT6) is a NAD+-dependent deacetylase associated with numerous aspects of health and physiology. Overexpression of SIRT6 has emerged as a protector in cardiac tissues against pathologic cardiac hypertrophy. However, the mechanism of this protective effect is not fully understood. Here, both in vivo and in vitro results demonstrated that SIRT6 overexpression can attenuate cisplatin-induced kidney injury in terms of renal dysfunction, inflammation and apoptosis. In addition, SIRT6 knockout aggravated kidney injury caused by cisplatin. We also found that SIRT6 bound to the promoters of ERK1 and ERK2 and deacetylated histone 3 at Lys9 (H3K9) thereby inhibiting ERK1/2 expression. Furthermore, inhibition of ERK1/2 activity eliminated aggravation of kidney injury caused by SIRT6 knock out. Thus, our findings uncover the protective effect of SIRT6 on the kidney and define a new mechanism by which SIRT6 regulates inflammation and apoptosis. This may provide a new therapeutic target for kidney injury under stress.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERK1/2; NF-κB; SIRT6; cisplatin; nephrotoxicity; p53

Mesh:

Substances:

Year:  2018        PMID: 29373150     DOI: 10.1016/j.kint.2017.10.021

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Endoplasmic reticulum stress contributes to cisplatin-induced chronic kidney disease via the PERK-PKCδ pathway.

Authors:  Shaoqun Shu; Hui Wang; Jiefu Zhu; Ying Fu; Juan Cai; Anqun Chen; Chengyuan Tang; Zheng Dong
Journal:  Cell Mol Life Sci       Date:  2022-07-27       Impact factor: 9.207

Review 2.  Cisplatin nephrotoxicity: new insights and therapeutic implications.

Authors:  Chengyuan Tang; Man J Livingston; Robert Safirstein; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2022-10-13       Impact factor: 42.439

3.  Numb Promotes Autophagy through p53 Pathway in Acute Kidney Injury Induced by Cisplatin.

Authors:  Ze Liu; Yong Li; Yongmei He; Junjie Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2022-06-27       Impact factor: 4.133

4.  Sirtuin 6 overexpression relieves sepsis-induced acute kidney injury by promoting autophagy.

Authors:  Yang Zhang; Ling Wang; Lei Meng; Guangke Cao; Yu Wu
Journal:  Cell Cycle       Date:  2019-01-30       Impact factor: 4.534

5.  Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.

Authors:  Zhixia Song; Jiefu Zhu; Qingqing Wei; Guie Dong; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

6.  Interferon-γ inhibits sirtuin 6 gene expression in intestinal epithelial cells through a microRNA-92b-dependent mechanism.

Authors:  Fangyi Liu; Xiao Wang; Hua Geng; Heng-Fu Bu; Peng Wang; Isabelle G De Plaen; Hong Yang; Jiaming Qian; Xiao-Di Tan
Journal:  Am J Physiol Cell Physiol       Date:  2020-02-12       Impact factor: 4.249

Review 7.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

8.  Roles of SIRT6 in kidney disease: a novel therapeutic target.

Authors:  Xueyan Yang; Jun Feng; Wei Liang; Zijing Zhu; Zhaowei Chen; Jijia Hu; Dingping Yang; Guohua Ding
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

Review 9.  The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury.

Authors:  Xun Zhou; Hui Chen; Yingfeng Shi; Xiaoyan Ma; Shougang Zhuang; Na Liu
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

Review 10.  Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update.

Authors:  Pía Loren; Nicolás Saavedra; Kathleen Saavedra; Tomás Zambrano; Patricia Moriel; Luis A Salazar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.